DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Diarrhoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Diarrhoea (149)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 149   Next >>

Possible Velcade side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Neurogenic Bladder, Neuropathy Peripheral, Syncope, Diarrhoea, Interstitial Lung Disease, Dizziness, Toxic Skin Eruption, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Piperacillin Tazobactam
    Indication: Infection

Velcade
    Dosage: 2.4 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-14
    End date: 2011-11-24

Other drugs received by patient: Mecobalamin; Lansoprazole; Uralyt / 01779901 /; Goshajinkigan; Acecol; Olopatadine HCL; Oxinorm / 00547301 /; Dexamethasone; Losartan Potassium



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: male

Reactions: Neuropathy Peripheral, Diarrhoea, Visual Acuity Reduced, Constipation

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in 71 year old male

Reported by a physician from United States on 2012-08-20

Patient: 71 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Diarrhoea, Haemorrhage Intracranial, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25
    End date: 2012-08-03

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25
    End date: 2012-08-03

Other drugs received by patient: Laxatives



Possible Velcade side effects in 4 year old female

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)

Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Cardiac Failure, Ileus, Diarrhoea, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk, cyclic

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-07-05

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-25



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-16

Patient:

Reactions: Nausea, Pain, Motor Dysfunction, Rash, Peripheral Sensory Neuropathy, Fatigue, Blood Potassium Decreased, Dyspepsia, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Doxorubicin HCL
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1
    Indication: Lymphoma

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Doxorubicin HCL
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1

Prednisone TAB
    Dosage: on days 1-5
    Administration route: Oral
    Indication: B-Cell Lymphoma

Prednisone TAB
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Waldenstrom's Macroglobulinaemia

Prednisone TAB
    Dosage: on days 1-5
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Prednisone TAB
    Dosage: on days 1-5
    Administration route: Oral

Prednisone TAB
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphoma

Prednisone TAB
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphocytic Lymphoma

Rituximab
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: maintenance
    Indication: Lymphocytic Lymphoma

Rituximab
    Dosage: maintenance
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: maintenance
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: maintenance
    Indication: Lymphoma

Rituximab
    Dosage: on day 1

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: B-Cell Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Waldenstrom's Macroglobulinaemia

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: Lymphocytic Lymphoma

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Waldenstrom's Macroglobulinaemia

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: B-Cell Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphocytic Lymphoma

Other drugs received by patient: Acetaminophen; Diphenhydramine Hydrochloride; Ondansetron



Possible Velcade side effects in

Reported by a physician from France on 2012-08-15

Patient:

Reactions: Diarrhoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1672 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-06-08

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-06-08

Velcade
    Dosage: 2899 unk, unk
    Indication: Multiple Myeloma
    Start date: 2012-06-08

Other drugs received by patient: Valaciclovir; Esomeprazole; Atovaquone; Phenoxymethylpenicillin; Sodium Bicarbonate; Allopurinol



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient:

Reactions: Neuropathy Peripheral, Diarrhoea

Drug(s) suspected as cause:
Revlimid

Velcade
    Indication: Multiple Myeloma



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male

Reactions: Diarrhoea

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from United Kingdom on 2012-08-10

Patient:

Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin Hydrochloride
    Dosage: 64 mg, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin Hydrochloride
    Dosage: 64 mg, qm
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Gabapentin; Amoxicillin; Furosemide; Acetaminophen; Furosemide; Enoxaparin Sodium



Possible Velcade side effects in

Reported by a physician from United Kingdom on 2012-08-10

Patient:

Reactions: Diarrhoea, Anaemia, Dizziness, Pulmonary Mycosis, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Doxorubicin HCL
    Dosage: 100 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Prednisolone
    Dosage: 100 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-08

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Velcade
    Dosage: 2.6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Other drugs received by patient: Prednisolone; Tramadol HCL; Chlorhexidine Gluconate; Omeprazole; Itraconazole; Acyclovir; Symbicort; Montelukast; Cetraben / 01561901 /; Fluconazole; Nitrofurantoin; Citalopram Hydrobromide; NEO-Mercazole TAB; Cotrim; Ferrous Fumarate; Ventolin; Enoxaparin Sodium; Metoclopramide



Possible Velcade side effects in

Reported by a physician from Finland on 2012-08-06

Patient:

Reactions: Diarrhoea, Orthostatic Hypotension, Thrombotic Thrombocytopenic Purpura, Haemolytic Uraemic Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.0 mg/m2, cyclic



Possible Velcade side effects in 55 year old male

Reported by a physician from United Kingdom on 2012-08-02

Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron Phosphate
    Dosage: 160 mg, qmo
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Decadron Phosphate
    Dosage: 160 mg, qmo
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin Hydrochloride
    Dosage: 64 mg/h, qmo
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin Hydrochloride
    Dosage: 64 mg, qmo
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Start date: 2010-10-18
    End date: 2010-11-10

Velcade
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Other drugs received by patient: Gabapentin; Acetaminophen; Amoxicillin; Enoxaparin Sodium; Furosemide



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-01

Patient:

Reactions: Nausea, Motor Dysfunction, Pain, Rash, Peripheral Sensory Neuropathy, Fatigue, Dyspepsia, Blood Potassium Decreased, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Cyclophosphamide
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Cyclophosphamide
    Dosage: on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Waldenstrom's Macroglobulinaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphocytic Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: maintenance
    Indication: Waldenstrom's Macroglobulinaemia

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: non-Hodgkin's Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: B-Cell Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Lymphoma

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: Lymphocytic Lymphoma

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Waldenstrom's Macroglobulinaemia

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Waldenstrom's Macroglobulinaemia

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphocytic Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: B-Cell Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphoma

Other drugs received by patient: Diphenhydramine HCL; Acetaminophen; Ondansetron



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-01

Patient:

Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin Hydrochloride
    Dosage: 64 mg, qm
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin Hydrochloride
    Dosage: 64 mg, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2, qd
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Acetaminophen; Amoxicillin; Furosemide; Furosemide



Possible Velcade side effects in

Reported by a physician from Netherlands on 2012-07-30

Patient:

Reactions: Diarrhoea, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-11

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-15

Velcade
    Dosage: 2.6 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-14



Possible Velcade side effects in 4 year old female

Reported by a consumer/non-health professional from United States on 2012-07-24

Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)

Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Diarrhoea, Ileus, Cardiac Failure, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-26

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-25



Possible Velcade side effects in female

Reported by a physician from United States on 2012-07-20

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Hyperaesthesia, Diarrhoea, Nausea, Haemoglobin Abnormal, Immunosuppressant Drug Level Increased, Blood Creatinine Increased, Micturition Urgency

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-12-15

Prednisone
    Dosage: 5 mg, cyclic
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-12-15

Rituximab
    Dosage: 314 mg, cyclic
    Indication: Renal Transplant
    Start date: 2011-10-20
    End date: 2011-10-20

Tacrolimus
    Dosage: 12 mg, cyclic
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-10-21
    End date: 2011-12-15

Thymoglobulin
    Dosage: 100 mg, cyclic
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-10-25

Velcade
    Dosage: 2 mg, cyclic
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-10-29

Other drugs received by patient: Nystatin; Albuterol; Colace; Bactrim; Coreg; Vitamin D; Synthroid; Topamax; Vitamin B-12; Miralax / 00754501 /; Percocet; Valcyte; Pepcid; Plaquenil



Possible Velcade side effects in

Reported by a consumer/non-health professional from United Kingdom on 2012-07-19

Patient:

Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg, qm
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, qd
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Amoxicillin; Furosemide; Furosemide; Enoxaparin Sodium; Acetaminophen; Gabapentin



Possible Velcade side effects in 76 year old male

Reported by a physician from France on 2012-07-19

Patient: 76 year old male, weighing 108.0 kg (237.6 pounds)

Reactions: Systemic Candida, General Physical Condition Abnormal, Pneumonia, Culture Stool Positive, Generalised Oedema, Renal Failure, Diarrhoea, Immunosuppression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone TAB
    Dosage: 40 mg, oral
    Administration route: Oral
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Doxorubicin HCL
    Dosage: 40 mg, intravenous
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Rituximab (Rituximab) Suspension FOR Injection
    Dosage: 857 mg, intravenous
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03

Velcade
    Dosage: 2 mg, intravenous
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Velcade
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 milligram/sq. meter



Possible Velcade side effects in 55 year old male

Reported by a physician from United Kingdom on 2012-07-16

Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg, qmo
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 mg, qmo
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg, qmo
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg/h, qmo
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Start date: 2010-10-18
    End date: 2010-11-10

Velcade
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Other drugs received by patient: Amoxicillin; Gabapentin; Acetaminophen; Furosemide; Enoxaparin Sodium



Possible Velcade side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: 69 year old female

Reactions: Injection Site Discolouration, Vomiting, Diarrhoea, Muscle Spasms

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a individual with unspecified qualification from United Kingdom on 2012-07-13

Patient:

Reactions: Diarrhoea, Multiple Myeloma

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg, unk
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 mg, unk
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg, unknown
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg, unknown
    Indication: Polyuria
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, unknown
    Indication: Anti-Infective Therapy
    Start date: 2010-09-27

Velcade
    Dosage: 2.4 mg/m2, unknown
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Acetaminophen; MK-0805; Gabapentin; Amoxicillin; MK-0805; Enoxaparin Sodium; Bebetina



Possible Velcade side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: female

Reactions: Death, Neuropathy Peripheral, Fatigue, Diarrhoea, Colitis Microscopic

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, qd
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-04-01
    End date: 2010-12-01

Revlimid
    Dosage: 25 mg, qd
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-03-01

Velcade
    Dosage: 2.4 mg, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-12-01
    End date: 2010-09-01

Other drugs received by patient: Aredia; Dexamethasone Sodium Posphate



Possible Velcade side effects in

Reported by a physician from Netherlands on 2012-07-12

Patient:

Reactions: Diarrhoea, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-11

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-15

Velcade
    Dosage: 2.6 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-14



Possible Velcade side effects in

Reported by a pharmacist from Netherlands on 2012-07-06

Patient:

Reactions: Diarrhoea, Oliguria, Colitis, Pyrexia, Thrombocytopenia, Leukopenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Valaciclovir; Cyclophosphamide; Fluconazole; Cotrim; Dexamethasone



Possible Velcade side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-06

Patient: 55 year old male

Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Administration route: Oral
    Start date: 2010-09-27
    End date: 2010-10-17

Dexamethasone Sodium Phosphate
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: dose unit:unknown
    Start date: 2010-09-27

Velcade
    Dosage: dose unit:unknown
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-10

Other drugs received by patient: Gabapentin; Acetaminophen; Melphalan Hydrochloride; Thalidomide; Furosemide; Dexamethasone Sodium Phosphate; Furosemide; Cyclophosphamide; Amoxicillin; Cyclophosphamide; Enoxaparin Sodium



Possible Velcade side effects in 4 year old female

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)

Reactions: Hypophosphataemia, Left Ventricular Dysfunction, Diarrhoea, Hyponatraemia, Acute Respiratory Distress Syndrome, Hypocalcaemia, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-26

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-20
    End date: 2012-06-25



Possible Velcade side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: male

Reactions: Fatigue, Neuropathy Peripheral, Diarrhoea, Dizziness, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-04

Patient: 55 year old male

Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Administration route: Oral
    Start date: 2010-09-27
    End date: 2010-10-17

Dexamethasone Sodium Phosphate
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: dose unit:unknown
    Start date: 2010-09-27

Velcade
    Dosage: dose unit:unknown
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-10

Other drugs received by patient: Enoxaparin Sodium; Amoxicillin; Dexamethasone Sodium Phosphate; Melphalan Hydrochloride; Cyclophosphamide; Thalidomide; Gabapentin; Acetaminophen



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017